Related Tags >> Bayer Avastin Sutent NICE

Nexavar News

Most Popular Nexavar Story

Bayer loses Yasmin patent fight

March 4, 2008 — 6:59am ET

Bayer had the Yasmin rug pulled out from under it yesterday. A U.S. court voided the contraceptive's key patent, leading the German conglomerate to revise its 2008 profit expectations Read more...

Nexavar Press Releases

In the United States, Nearly All Surveyed Physicians Prescribe Pfizer’s Sutent and a Significant Majority Prescribe Bayer/
Onyx Pharmaceuticals to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Onc
BioInvent and ThromboGenics Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Part
Ardea Biosciences to Present at Two Upcoming Investor Conferences

Latest Headlines

Nexavar disappoints in another lung-cancer trial
June 14, 2010
Study: Tailored lung-cancer therapy outperforms typical treatment
April 19, 2010
India's Cipla loads up for at-risk launch of generic Nexavar
April 9, 2010
Indian patent system draws more pharma ire
February 12, 2010
Nexavar, Herceptin could gain from cancer meeting
December 14, 2009
NICE spurns Avastin for bowel cancer
November 25, 2009
Bayer's better Nexavar offer not NICE enough
November 19, 2009
NICE says no to Nexavar in liver cancer
September 10, 2009
NICE rejects kidney cancer meds, again
August 26, 2009
Existing drugs to watch at ASCO
May 29, 2009
NICE nixes Nexavar for liver cancer
May 7, 2009
Nexavar expected to bloom in Europe
December 11, 2008
NICE to green-light costly kidney meds
December 1, 2008
Bayer: Nexavar study shows survival boost
October 31, 2008
NICE rejects four cancer meds
August 7, 2008
Alimta, Nexavar look for ASCO boost
May 16, 2008
Alimta, Nexavar look for ASCO boost
May 16, 2008
ALSO NOTED: China accuses U.S. of obstructing heparin probe; GSK exec charges Mass. with demonizing pharma;
May 7, 2008
Bayer loses Yasmin patent fight
March 4, 2008
Bayer lower 2008 expectations
February 29, 2008

Paid Research Reports

More Research Reports >>